$PTGX
Protagonist Therapeutics, Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Newark, CA
PTGX chart
What traders are saying about $PTGX
Latest postsProtagonist Therapeutics, Inc news
- Wedbush reiterates Protagonist Therapeutics stock rating on oral focus
Investing.com ·
- Protagonist Therapeutics, Inc. $PTGX Shares Sold by State of Wyoming
MarketBeat ·
- How Investors Are Reacting To Protagonist Therapeutics Stock After Royalty Fueled Profitability
Simply Wall St ·
- symbol__ Stock Quote Price and Forecast
CNN ·
- Wall Street Zen Upgrades Protagonist Therapeutics (NASDAQ:PTGX) to "Strong-Buy"
MarketBeat ·
- Protagonist Therapeutics (NASDAQ:PTGX) Announces Earnings Results, Beats Estimates By $0.57 EPS
MarketBeat ·
- Protagonist Therapeutics, Inc. (PTGX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- HC Wainwright Forecasts Strong Price Appreciation for Protagonist Therapeutics (NASDAQ:PTGX) Stock
MarketBeat ·
- HC Wainwright & Co. maintains Protagonist Therapeutics at Buy, raises price target to $221 from $170
TradingView ·
- Protagonist Therapeutics (PTGX) Stock Looks Priced At A Premium As Its 7x Three Year Run Continues
Yahoo Finance ·
- BMO Capital Maintains Protagonist Therapeutics(PTGX.US) With Buy Rating, Raises Target Price to $190
Moomoo ·
- Protagonist Therapeutics 3Q 2026: Revenue $274.41M, EPS $3.07 — 10-Q Summary
TradingView ·
Protagonist Therapeutics, Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$130.1M | $275.2M | -$79.0M | -$127.4M |
| Diluted EPS | $-2.05 | $4.23 | $-1.39 | $-2.60 |
| Total assets (year end) | $668.2M | $744.7M | $358.0M | $247.9M |
| Cash and equivalents (year end) | $128.4M | $97.2M | $186.7M | $125.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Protagonist Therapeutics, Inc
- Ticker
- PTGX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Newark, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1377121
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
Frequently asked questions
What exchange is Protagonist Therapeutics, Inc listed on?
Protagonist Therapeutics, Inc trades on the Nasdaq under the ticker symbol PTGX.
What industry is Protagonist Therapeutics, Inc in?
Protagonist Therapeutics, Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Protagonist Therapeutics, Inc headquartered?
Protagonist Therapeutics, Inc's business address on file with the SEC is in Newark, CA.
When does Protagonist Therapeutics, Inc's fiscal year end?
Protagonist Therapeutics, Inc's fiscal year ends on December 31.